Dr Ruth Langley

Dr Ruth Langley is based at the UK Medical Research Council Clinical Trials Unit at University College London where she jointly leads the Cancer Group; and has a clinical consultant post at the Brighton and Sussex University Hospital.

She has a particular interest in gastro-oesophageal malignancy and has co-ordinated a series of trials and associated translational studies, and has led the investigation of the use of transdermal oestrogen in the treatment of prostate cancer.

Dr Langley is the Chief Investigator of an international trial (Add-Aspirin) designed to assess the effect of aspirin as an additional adjuvant agent in several common solid tumours.